AJKD Blog

Kidney transplant recipients are at least twice as likely to develop cancer compared with immunocompetent people. Cancer is now the second leading cause of death in kidney transplant recipients. In a recent Core Curriculum published in AJKD, the authors review...

Dr. Natasha Freeman is an Assistant Professor in Nephrology, specializing in glomerular diseases, at Columbia University Irving Medical Center. She received her MD from the Columbia University Vagelos College of Physicians and Surgeons and a MS i...

Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers will find this valuable in helping them keep up with the latest research in the field of nephrology.

Highlights f...

For many years, the only specific pharmacologic intervention to decrease end-stage kidney disease in diabetic kidney disease was renin-angiotensin-aldosterone system blockade. Despite the addition of new interventions recently, there remains a need for new therapies. A recent Mini Review published in AJKD by

Dr. Ifeoluwa Stowe is a nephrology fellow at Beth Israel Deaconess Medical Center/Harvard Medical School. She was born and raised in Nigeria where she completed medical school at the University of Lagos. She thereafter completed her Internal Medic...